Points to Consider on the Statistical Analysis of Rodent Cancer Bioassay Data When Incorporating Historical Control Data

Toxicologic Pathology

Volumn 37, Issue 5, 2009, Pages 672-676

  Elmore, Susan A ^a,b   Peddada, Shyamal D ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

boxplot; historical control data; IQR; lower quartile; median; range; upper quartile

Indexed keywords

BIOASSAY; CANCER INCIDENCE; CANCER MODEL; CANCER STATISTICS; CARCINOGENICITY; DATA ANALYSIS; DISEASE MODEL; HEPATOBLASTOMA; HISTORICAL CONTROL DATA; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; RODENT; RODENT DISEASE; STATISTICAL ANALYSIS; ANIMAL; ARTICLE; CARCINOGEN TESTING; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL NEOPLASM; FACTUAL DATABASE; FEMALE; MALE; METHODOLOGY; RAT;

RODENTIA;

ANIMALS; CARCINOGENICITY TESTS; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; FEMALE; MALE; NEOPLASMS, EXPERIMENTAL; RATS;

EID: 70350453664     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/0192623309339606     Document Type: Article

References (20)

1. Bailer AJ Portier CJ Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples Biometrics 1988 44 417 31
2. Baldrick P Carcinogenicity evaluation: Comparison of tumor data from dual control groups in the Sprague-Dawley rat Toxicol Pathol 2005 33 283 91
3. Benjamini Y Opening the box of a boxplot The American Statistician 1988 42 257 62
4. Bieler GS Williams RL Ratio estimates, the delta method, and quantal response tests for increasedcarcinogenicity Biometrics 1993 49 793 801
5. Dawson B Trapp R Basic and clinical biostatistics 2004 4th ed New York McGraw-Hill Medical Publishers
6. Dempster AP Selwyn MR Weeks BJ Combining historical and randomized controls for assessing trends in proportions J Amer Stat Assoc 1983 78 221 27
7. Dunson DB Dinse GE Bayesian incidence analysis of animal tumorigenicity data Appl Stat 2001 50 125 41
8. Eiben R Bomhard EM Trends in mortality, body weights and tumor incidences of Wistar rats over 20 years Exp Toxicol Pathol 1999 51 523 36
9. Haseman JK Arnold J Eustis SL Boorman GA Eustis SL Elwell MR Montgomery CA Mackenzie WF Tumor incidences in Fischer 344 rats: NTP historical data Pathology of the Fischer rat reference and atlas 1990 San Diego, CA Academic Press 555 64
10. Hoel DG Sen PK Conditional two sample tests with historical controls Contributions to Statistics 1983 North-Holland, Amsterdam, the Netherland 229 36
11. Hoel DG Yanagawa T Incorporating historical controls in testing for a trend in proportions J Amer Stat Assoc 1986 81 1095 99
12. Ibrahim JG Ryan LM Use of historical controls in time-adjusted trend tests for carcinogenicity Biometrics 1996 52 1478 85
13. Ibrahim JG Ryan LM Chen M Using historical controls to adjust for covariates in trend tests for binary data J Amer Stat Assoc 1998 93 1282 93
14. Peddada S Dinse G Kissling G Incorporating historical control data when comparing tumor incidence rates J Amer Stat Assoc 2007 102 1212 20
15. Portier CJ Bailer AJ Testing for increased carcinogenicity using survival–adjusted quantal response test Fundam Appl Toxicol 1989 12 731 37
16. Prentice RL Smythe RT Krewski D Mason M On the use of historical control data to estimate dose response trends in quantal bioassay Biometrics 1992 48 459 78
17. Tamura RN Young SS The incorporation of historical information in tests of proportions: Simulation study of Tarone’s procedure Biometrics 1986 42 343 49
18. Tamura RN Young SS A stabilized moment estimator for the beta-binomial distribution Biometrics 1987 43 813 24
19. Tarone RE The use of historical control information in testing for a trend in proportions Biometrics 1982 38 215 20
20. U.S. Food and Drug Administration Center for Drug Evaluation and Research Guidance for Industry: Statistical Aspects of the Design, Analysis and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals (section C) 2001 http://www.fda.gov/cder/guidance/815dft.htm